Physician profile
Jay Van Wright
NPI 1932158292
$4,140.78
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $371 · 2021: $810 · 2022: $910 · 2023: $932 · 2024: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,366.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $675.61 | 2021-2024 | Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $618.78 | 2019-2023 | Lifevest |
| Edwards Lifesciences Corporation | $424.58 | 2019-2021 | |
| Abbott Laboratories | $284.44 | 2019-2024 | Jot Dx, Xience Sierra |
| E.R. Squibb & Sons, L.L.C. | $277.55 | 2019-2024 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $267.47 | 2019-2022 | |
| Pfizer INC. | $232.04 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $222.68 | 2020-2024 | |
| Boston Scientific Corporation | $172.70 | 2019-2023 | Lux-Dx Insertable Cardiac Monitor |
| Alnylam Pharmaceuticals INC. | $162.64 | 2021-2024 | Onpattro |
| Astrazeneca Pharmaceuticals Lp | $112.41 | 2020-2024 | Farxiga |
| Amgen INC. | $100.92 | 2019-2023 | Repatha |
| Merck Sharp & Dohme LLC | $92.12 | 2022-2023 | Verquvo |
| Philips North America LLC | $85.47 | 2020-2024 | (Ck4) Mcot |
| Kiniksa Pharmaceuticals, Ltd. | $79.61 | 2021-2023 | Arcalyst |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $47.97 | 2022 | |
| Amarin Pharma, INC. | $47.46 | 2019 | |
| Chiesi USA, INC. | $37.45 | 2022-2023 | Cleviprex, Kengreal |
| Atricure, INC. | $37.43 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $31.59 | 2019 | |
| Cvrx, INC. | $24.39 | 2024 | Barostim Neo System |
| Inspire Medical Systems, INC. | $22.77 | 2023 | Inspire |
| Vital Connect, INC | $20.79 | 2023 | Vitalpatch Rtm |
| Bayer Healthcare Pharmaceuticals INC. | $17.68 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $15.49 | 2023 | Inpefa |
| Bardy Diagnostics, INC. | $15.00 | 2020 | |
| Teleflex LLC | $13.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.